Home » Stocks » AMRN

Amarin Corporation Plc (AMRN)

Stock Price: $4.69 USD -0.14 (-2.90%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed
After-hours: $4.68 -0.01 (-0.21%) Oct 28, 7:56 PM

Stock Price Chart

Key Info

Market Cap 1.81B
Revenue (ttm) 546.00M
Net Income (ttm) -12.53M
Shares Out 385.85M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE 15.08
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $4.69
Previous Close $4.83
Change ($) -0.14
Change (%) -2.90%
Day's Open 4.76
Day's Range 4.58 - 4.80
Day's Volume 3,274,619
52-Week Range 3.36 - 26.12

More Stats

Market Cap 1.81B
Enterprise Value 1.29B
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 385.85M
Float 376.90M
EPS (basic) -0.04
EPS (diluted) -0.03
FCF / Share 0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.92%
Payout Ratio n/a
Shares Short 24.86M
Short Ratio 3.08
Short % of Float 6.59%
Beta 2.81
PE Ratio n/a
Forward PE 15.08
P/FCF Ratio 108.95
PS Ratio 3.31
PB Ratio 3.25
Revenue 546.00M
Operating Income -18.90M
Net Income -12.53M
Free Cash Flow 16.61M
Net Cash 522.43M
Net Cash / Share 1.35
Gross Margin 61.12%
Operating Margin -3.46%
Profit Margin -2.30%
FCF Margin 3.04%
ROA -1.81%
ROE -3.33%
ROIC -5.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (13)

Buy 8
Overweight 0
Hold 5
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(143.07% upside)
Current: $4.69
Target: 11.40
*Average 12-month price target from 10 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth87.49%26.56%39.22%59.11%50.84%105.69%----
Gross Profit33417513695.7253.8833.7214.44---
Operating Income-24.28-108-45.56-65.63-98.22-95.96-182-117-44.16-45.10
Net Income-22.65-116-67.87-86.35-115-56.36-166-179-69.13-250
Shares Outstanding343297271212181174161144130100
Earnings Per Share-0.07-0.39-0.25-0.41-0.83-0.36-1.28-1.24-0.53-2.49
Operating Cash Flow-9.37-94.70-32.84-71.82-84.02-74.61-190-122-39.44-33.87
Capital Expenditures-2.48-0.06-0.01-0.02-0.03--0.01-12.69-0.40-0.02
Free Cash Flow-11.84-94.76-32.85-71.84-84.05-74.61-190-135-39.84-33.89
Cash & Equivalents64825174.2498.8510812019326011731.44
Total Debt59.5780.35123116251234261234-0.09
Net Cash / Debt589170-48.42-17.60-144-114-68.5926.2611731.35
Book Value608152-65.10-9.06-128-88.45-33.86-4.00-5.96-202
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Amarin Corporation Plc
Country Ireland
Employees 965
CEO John F. Thero

Stock Information

Ticker Symbol AMRN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AMRN
IPO Date April 1, 1993


Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Company to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.